Search
for

    Sort by

    Research 331–360 of 1000+

    1. Finasteride treatment and neuroactive steroid formation. PubMed · 2009 · 9 citations
    2. Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals 2025
    3. Evaluating Carthamus Oxyacantha For 5α-Reductase Inhibition: Therapeutic Perspectives In BPH Journal for ReAttach Therapy and Developmental Diversities · 2023
    4. Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование Курский научно-практический вестник "Человек и его здоровье" · 2012
    5. 5α‐Reductase inhibitors and prostatic disease Clinical endocrinology · 1994 · 21 citations
    6. Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human Endocrinology · 1985 · 193 citations
    7. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Proceedings of the National Academy of Sciences of the United States of America · 1993 · 53 citations
    8. A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. PubMed · 2005 · 52 citations
    9. New 5?-reductase inhibitors: In vitro and in vivo effects Steroids · 2005 · 45 citations
    10. Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase. PubMed · 2005 · 38 citations
    11. Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie Der Urologe · 2002 · 24 citations
    12. 5α-reductase inhibitors/finasteride The Prostate · 1996 · 24 citations
    13. 황금(黃芩)이 전립선비대증(前立腺肥大症) Rat에 미치는 영향 The Journal of Internal Korean Medicine · 2009 · 2 citations
    14. Clinical research on preoperative application of finasteride in reducing transurethral resection syndrome Shandong yiyao · 2013 · 1 citations
    15. Alternative androgen pathways WikiJournal of Medicine · 2023
    16. Effects of Castration on BPH 2016
    17. Review: Adding α<sub>1</sub>-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men Annals of Internal Medicine · 2014
    18. Associations between semen quality and lower urinary tract symptoms in ageing male Journal of Men's Health · 2010
    19. 102 Methylation of CpG islands in promoter of type 2 5-α reductase and implications of finasteride resistance for BPH therapy European Urology Supplements · 2016
    20. ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW Archiv Euromedica · 2026
    21. Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients The Journal of Sexual Medicine · 2010 · 223 citations
    22. Clinical application of 5α-reductase inhibitors Journal of endocrinological investigation · 2001 · 46 citations
    23. PNU 157706, a novel dual type I and II5α-reductase inhibitor The Journal of Steroid Biochemistry and Molecular Biology · 1998 · 42 citations
    24. 5-Alpha reductase deficiency Current Opinion in Endocrinology, Diabetes and Obesity · 2014 · 38 citations
    25. 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives International Journal of Biological Macromolecules · 2011 · 26 citations
    26. The Role of Non-Aromatizable Testosterone Metabolite in Metabolic Pathways Physiological Research · 2011 · 21 citations
    27. Comparison of clinical trials with finasteride and dutasteride. PubMed · 2004 · 20 citations
    28. Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study Urologic Oncology: Seminars and Original Investigations · 2018 · 13 citations
    29. Common urologic diseases in older men and their treatment: how they impact fertility Fertility and Sterility · 2017 · 8 citations
    30. An update on the use of 5alpha-reductase inhibitors Drugs of today · 2004 · 7 citations